Exosome Therapy
— When Cells Write Letters
Exosomes are nanoscale vesicles through which cells exchange molecular information. What basic research knows about these fascinating messengers — and what this can mean for contemporary skincare.
What Exosomes Are
In current basic research, exosomes are considered one of the most fascinating discoveries in cell biology — tiny nanovesicles that communicate between cells, transmitting molecular information that can profoundly influence the behavior of their recipient cells. What was long considered cellular "waste" is now understood as a highly precise communication system active in almost every tissue of the human body — including the skin.
In dermatological research, exosomes are increasingly coming into focus because they can modulate a number of cellular processes considered relevant to skin health: from the extracellular matrix to barrier function and signaling pathways associated with visible skin aging. The literature describes both naturally occurring exosomes from endogenous sources and biotechnologically derived equivalents from plant cells and stem cell cultures — a field that is developing at a remarkable pace.
smaller than most cell organelles
contained in a single exosome
in the last five-year period
Mechanisms of Action
Exosomes originate inside cells, specifically in multivesicular bodies (MVBs), which fuse with the cell membrane and release the vesicles into the extracellular space. Their cargo — consisting of proteins, lipids, mRNA, miRNA, and other non-coding RNA molecules — reflects the state of the origin cell and can be taken up by recipient cells, where it can initiate signaling cascades. For the skin, the following mechanisms are primarily described in the literature:
Exosomes act as natural messengers between keratinocytes, fibroblasts, and immune cells of the skin. Research describes that miRNA species transmitted by these vesicles can modulate gene expression patterns in recipient cells — including those associated with collagen synthesis and oxidative stress management. This "paracrine" communication pathway is considered a central element of tissue homeostasis in the literature.
Various in-vitro studies suggest that exosomes from mesenchymal stem cells can influence the proliferation of dermal fibroblasts and shift the expression patterns of matrix proteins such as type I collagen and elastin. Whether and to what extent such effects are transferable to topical application in cosmetic formulations is still debated in current literature — penetration depth is considered one of the central research questions.
A recurring finding in the literature concerns the ability of certain exosome populations to influence inflammation-associated signaling cascades. In particular, plant exosome-like nanoparticles (PELNs) — for example, those derived from ginger or turmeric — are being investigated in preclinical models for their effects on pro-inflammatory cytokines. These findings are still preliminary but open an interesting window for the connection with inflammaging and preventive skincare.
Exosomes are biologically fascinating — but research into their topical efficacy in cosmetic applications is still in its early stages. Clinically well-documented effects so far primarily come from in-vitro models and medical application contexts, not from controlled cosmetic studies. This makes exosomes a promising but still immature active ingredient field.
Many commercially available exosome products do not specify the concentration, exact origin, or stabilization form of their exosome fraction. Since exosomes are temperature- and light-sensitive, the question of formulation stability is crucial for actual efficacy — an aspect often underestimated in product selection.
Sources of Exosomes in Cosmetics
The classification of exosomes used in cosmetics is primarily based on their origin — this determines the molecular cargo, safety profile, and regulatory requirements for the finished product.
The most frequently studied category in the literature are exosomes from mesenchymal stem cells (MSC-exosomes). They are characterized by a particularly rich cargo of growth factors and non-coding RNAs and are investigated in research in the context of tissue regeneration and wound healing. For cosmetic application, regulatory and production-related issues are not yet considered conclusively resolved.
PELNs from sources such as aloe vera, grapefruit, or green tea are increasingly present in the literature because they are biotechnologically more accessible than human equivalents and do not create ethical dilemmas. Researchers describe a certain affinity of some of these particles for mammalian cells and a potential ability to introduce bioactive molecules into target cells — although the transferability to topical applications is still a subject of active discussion.
A newer research direction focuses on the targeted production of exosomes in the laboratory — either by optimizing natural cell sources or by completely synthetic vesicles that mimic exosomes in their structure. The goal is precisely controllable cargo with simultaneously standardized production. In cosmetic research, this approach is considered particularly promising because it can combine scalability and purity — although regulatory frameworks for the market are still under development.
In the medical field, exosome preparations are considered medicinal products and are subject to strict approval. In the cosmetic sector, many products operate in a regulatory gray area: declared as "bioactive complex" or "stem cell extract," they often evade precise classification. For consumers, it is crucial: what is stated on the packaging and what is biologically active in the product can differ significantly.
What This Means for Skincare
Exosome formulations in cosmetics are at the intersection of basic research and application. The question of whether topically applied exosomes can penetrate the skin barrier in sufficient concentration to induce cellular effects has not yet been conclusively answered scientifically. The quality of the formulation is crucial: stabilization, concentration, and carrier substance determine how much of the bioactive cargo reaches its target structure.
- Intact skin barrier as a prerequisite for penetration
- Evening application (increased readiness for regeneration)
- Combination with niacinamide for barrier synergy
- Light-protected, cool storage of the product
- Consistent application over several weeks
- Transparent manufacturer information on concentration & source
- Compromised barrier (reduced penetration depth)
- Heat and light exposure (vesicle instability)
- Too low or undeclared concentration
- Lack of information on exosome origin & processing
- Combination with strongly acidic active ingredients (pH instability)
"Exosomes speak the language of cells — but whether this message is received with topical application is a question of formulation."
Field Notes: Skin Barrier · Field Notes: Inflammaging · Field Notes: NAD⁺ & Skin Longevity
The NATURFACTOR® Porcelain Skin Serum (day care) and the Blue Crystal Drops (night care) are designed as a synergistic system that accompanies the skin's natural signaling processes in its active regeneration phase.
A Note on Dermatology
Exosome-based therapies in the medical field — for example, for wound healing or hair regeneration — are evaluated and regulated differently clinically than cosmetic formulations. Anyone suffering from a specific skin condition or considering targeted regenerative applications should discuss this with a dermatologist. Cosmetic exosome products are not a substitute for medical treatment.
Frequently Asked Questions
Are exosomes in cosmetic products truly biologically active?
That depends crucially on manufacturing and formulation. Exosomes are delicate vesicles — heat, light, and an unfavorable pH can destabilize their membrane structure and thus their cargo. Whether a commercial product still contains functionally active exosomes is almost impossible to assess without manufacturer transparency. Well-documented products with validated stability data are the exception, not the rule.
What is the difference between human and plant exosomes?
Human exosomes — for example, from mesenchymal stem cells — carry endogenous signaling molecules such as growth factors and human miRNAs. Plant exosome-like nanoparticles (PELNs) have a different molecular composition and interact with human cells via different signaling pathways. Both can, according to the literature, induce biological effects — however, the comparability of their effects is limited, and clinical research on PELNs is still in its early stages.
How does an exosome cream differ from a conventional active ingredient cream?
A conventional active ingredient cream contains defined molecules with known mechanisms of action (e.g., retinol, niacinamide, hyaluronic acid). Exosome formulations contain biological vesicles with a complex, variable cargo — their efficacy profile is broader but also less precisely controllable. This makes exosomes scientifically interesting but more demanding in quality control than classic cosmetic raw materials.
Who are exosome formulations particularly interesting for?
From a scientific perspective, exosome formulations can be interesting for skin that tolerates classic active ingredients like retinoids poorly, as exosome signals address more subtle mechanisms. The research field is also promising in the context of inflammaging and mature skin. For younger, barrier-stable skin, there is currently no convincing clinical evidence for added value compared to established active ingredients.
- Théry, C. et al. (2009). Membrane vesicles as conveyors of immune responses. Nature Reviews Immunology, 9(8), 581–593.
- Cho, B. S. et al. (2018). Human adipose-derived stem cell-conditioned medium and exosomes promote wound healing. Journal of Dermatological Science, 91(2), 143–151.
- Suharta, S. et al. (2021). Plant-derived exosome-like nanoparticles as a potential beneficial material. Journal of Applied Pharmaceutical Science, 11(4), 001–009.
- Tominaga, N. et al. (2020). Exosomes: Key players in cancer and potential therapeutic strategy. Signal Transduction and Targeted Therapy, 5(1), 1–10.
- Wiklander, O. P. B. et al. (2019). Advances in therapeutic applications of extracellular vesicles. Science Translational Medicine, 11(492), eaav8521.
